AR015962A1 - LANTIBIoTICO RELACIONADO CON ACTAGARDINA, PROCEDIMIENTO PARA SU PREPARACIoN, MEDICAMENTO, PROCEDIMIENTO PARA LA PREPARACIoN DE UN MEDICAMENTO Y EMPLEO DEL MISMO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA ENFERMEDADES INFECCIOSAS BACTERIANAS. - Google Patents

LANTIBIoTICO RELACIONADO CON ACTAGARDINA, PROCEDIMIENTO PARA SU PREPARACIoN, MEDICAMENTO, PROCEDIMIENTO PARA LA PREPARACIoN DE UN MEDICAMENTO Y EMPLEO DEL MISMO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA ENFERMEDADES INFECCIOSAS BACTERIANAS.

Info

Publication number
AR015962A1
AR015962A1 ARP980105093A ARP980105093A AR015962A1 AR 015962 A1 AR015962 A1 AR 015962A1 AR P980105093 A ARP980105093 A AR P980105093A AR P980105093 A ARP980105093 A AR P980105093A AR 015962 A1 AR015962 A1 AR 015962A1
Authority
AR
Argentina
Prior art keywords
preparation
procedure
medicinal product
lantibiotic
actagardine
Prior art date
Application number
ARP980105093A
Other languages
English (en)
Original Assignee
Gompel Marie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gompel Marie filed Critical Gompel Marie
Publication of AR015962A1 publication Critical patent/AR015962A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente se refiere a un nuevo lantibiotico con la formula NH2-R-actagardina, significando NH2-R el resto del aminoácido alanina, que se forma durantela fermentacion por el microorganismo Actinoplanes liguriae DSM 11797 o Actinoplanesgarbadiensis DSM 11796, a derivados químicos del lantibiotico, a unprocedimiento para su preparacion y al empleo de los lantibioticos como medicamento.
ARP980105093A 1997-10-15 1998-10-13 LANTIBIoTICO RELACIONADO CON ACTAGARDINA, PROCEDIMIENTO PARA SU PREPARACIoN, MEDICAMENTO, PROCEDIMIENTO PARA LA PREPARACIoN DE UN MEDICAMENTO Y EMPLEO DEL MISMO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA ENFERMEDADES INFECCIOSAS BACTERIANAS. AR015962A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19745583A DE19745583A1 (de) 1997-10-15 1997-10-15 Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben

Publications (1)

Publication Number Publication Date
AR015962A1 true AR015962A1 (es) 2001-05-30

Family

ID=7845627

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105093A AR015962A1 (es) 1997-10-15 1998-10-13 LANTIBIoTICO RELACIONADO CON ACTAGARDINA, PROCEDIMIENTO PARA SU PREPARACIoN, MEDICAMENTO, PROCEDIMIENTO PARA LA PREPARACIoN DE UN MEDICAMENTO Y EMPLEO DEL MISMO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA ENFERMEDADES INFECCIOSAS BACTERIANAS.

Country Status (15)

Country Link
US (1) US6022851A (es)
EP (1) EP0916680B1 (es)
JP (1) JP3684432B2 (es)
KR (1) KR100482402B1 (es)
CN (1) CN1165547C (es)
AR (1) AR015962A1 (es)
AT (1) ATE258558T1 (es)
AU (1) AU739516C (es)
BR (1) BRPI9803914B1 (es)
CA (1) CA2250630C (es)
DE (2) DE19745583A1 (es)
DK (1) DK0916680T3 (es)
ES (1) ES2213862T3 (es)
HK (1) HK1020739A1 (es)
PT (1) PT916680E (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
EP1908774A1 (en) * 2006-10-06 2008-04-09 sanofi-aventis Antibacterial and antiviral peptides from Actinomadura namibiensis
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
WO2010058238A1 (en) * 2008-11-24 2010-05-27 Sentinella Pharmaceuticals, Inc. ("Sentinella") Lantibiotic carboxyamide derivatives with enhanced antibacterial activity
GB0900599D0 (en) * 2009-01-14 2009-02-18 Novacta Biosystems Ltd Treatment
JP5719312B2 (ja) 2009-01-14 2015-05-13 ノヴァクタ バイオシステムズ リミティッド デオキシアクタガルジン誘導体
CA2750883A1 (en) 2009-02-04 2010-08-12 Novacta Biosystems Limited Actagardine derivatives
GB201001688D0 (en) * 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
EP2701718A4 (en) * 2011-03-30 2014-11-19 Sentinella Pharmaceuticals Inc LANTIBIOTIC NAI-802, PHARMACEUTICALLY ACCEPTABLE SALTS, ITS COMPOSITIONS, AND USES THEREOF
AU2015237357B2 (en) * 2014-03-25 2019-04-18 Lanthiopep B.V. Cyclic apelin analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1470407A (en) * 1974-07-27 1977-04-14 Lepetit Spa Antibiotic substances
GB8507528D0 (en) * 1985-03-22 1985-05-01 Lepetit Spa Basis monocarboxyamide derivatives
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions

Also Published As

Publication number Publication date
HK1020739A1 (en) 2000-05-19
KR100482402B1 (ko) 2005-08-31
JP3684432B2 (ja) 2005-08-17
AU739516B2 (en) 2001-10-11
US6022851A (en) 2000-02-08
DE19745583A1 (de) 1999-04-22
CN1165547C (zh) 2004-09-08
EP0916680B1 (de) 2004-01-28
CA2250630A1 (en) 1999-04-15
BR9803914A (pt) 2000-03-28
DK0916680T3 (da) 2004-05-24
EP0916680A3 (de) 2001-10-17
EP0916680A2 (de) 1999-05-19
BRPI9803914B1 (pt) 2016-11-01
KR19990037179A (ko) 1999-05-25
DE59810658D1 (de) 2004-03-04
ATE258558T1 (de) 2004-02-15
PT916680E (pt) 2004-06-30
JPH11193299A (ja) 1999-07-21
CA2250630C (en) 2008-07-15
AU739516C (en) 2002-05-02
ES2213862T3 (es) 2004-09-01
AU8926198A (en) 1999-05-06
CN1221752A (zh) 1999-07-07

Similar Documents

Publication Publication Date Title
AR015962A1 (es) LANTIBIoTICO RELACIONADO CON ACTAGARDINA, PROCEDIMIENTO PARA SU PREPARACIoN, MEDICAMENTO, PROCEDIMIENTO PARA LA PREPARACIoN DE UN MEDICAMENTO Y EMPLEO DEL MISMO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA ENFERMEDADES INFECCIOSAS BACTERIANAS.
ES2130265T3 (es) Region de union al receptor de la toxina difterica.
NO951198L (no) Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
BR0113234A (pt) Polimorfos de um análogo de epotilona
BR0112589A (pt) Derivados de heteroarila e sua aplicação como medicamento
IL162917A0 (en) A lysin from bacteriophage and pharmaceutical compositions containing the same
DE69908885T2 (de) NEUARTIGES AUS -i(PARASILURUS ASOTUS) ISOLIERTES ANTIMIKROBIELLES PEPTID UND SEINE VERWENDUNG
IL94862A0 (en) Antibiotic compound,its production and pharmaceutical compositions containing it
ES2064398T3 (es) Un nuevo antibiotico, mersacidina, un procedimiento para su preparacion y su utilizacion como medicamento.
DK165120C (da) Basiske monokarboxyamidderivater af actagardin, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende derivaterne
EA200100700A1 (ru) Гены и белки и их применение
ATE3416T1 (de) Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
ES2135023T3 (es) Utilizacion de un decapeptido con actividad de tipo benzodiazepina para la preparacion de medicamentos y complementos alimentarios.
DK0552106T3 (da) Peptider med antagonistaktivitet over for bradykinin
NZ533738A (en) Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis
HUP0401586A2 (hu) Baktériumellenes szer
EP2013234B1 (en) Peptide compound with biological activity, its preparation and its application
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
ES2175582T3 (es) Cromanos sustituidos con sulfonamida, procedimiento para su preparacion, su utilizacion como medicamento, asi como preparados farmaceuticos que los contienen.
FI961505A0 (fi) Uudet veren koaguloitumisjärjestelmässä terapeuttisesti aktiiviset peptidiyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
BRPI0417798A (pt) proteìna de membrana externa de 72 kda de brachyspira pilosicoli e usos diagnósticos e terapêuticos da mesma
ES2038244T3 (es) Procedimiento para preparar un nuevo antibiotico, fumifungina, y su empleo como medicamento.
DE60022995D1 (de) Impfstoff
AP1684A (en) Dithiocarbamate derivatives and their use as antibacterial agents.
TH126305A (th) อนุพันธุ์เพพไทด์ vapeehptllteaplnpk ที่มีการกระตุ้นทางชีวภาพ

Legal Events

Date Code Title Description
FG Grant, registration